The North American Cysticercosis Consortium was formed in 2009 to promote collaboration and sharing of resources in the study of neurocysticercosis among clinicians and research scientists in North America. An estimated 1,500 cases of neurocysticercosis are diagnosed each year in the United States.
Main Areas of Focus
- To further the study and rational treatment of neurocysticercosis in North America
- To determine the feasibility of conducting collaborative, multicenter studies of neurocysticercosis
- To pool the experience of practitioners in North America who are involved in the management of this disease
Members of this consortium are a select group of infectious disease physicians, neurologists, and scientists who have a strong interest in neurocysticercosis. The participants’ interests and expertise attract a variety of patients with complex and difficult-to-treat disease, which mostly consists of subarachnoid neurocysticercosis.